FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended September 30, 2011. Total revenues for the third quarter of 2011 were $2.12 billion, up 9 percent compared to total revenues of $1.94 billion for the third quarter of 2010. Net income for the third quarter of 2011 was $741.1 million, or $0.95 per diluted share, compared to net income for the third quarter of 2010 of $704.9 million, or $0.83 per diluted share. Non-GAAP net income for the third quarter of 2011, which excludes after-tax acquisition-related, restructuring and stock-based compensation expenses, was $795.2 million, or $1.02 per diluted share, compared to non-GAAP net income for the third quarter of 2010 of $759.7 million, or $0.90 per diluted share.
